HALCYGEN PHARMACEUTICALS LIMITED
HGN - Submission of IND Application to US FDA - Dr Roger Aston, CEO
Wed, 14 May 2008 05:30PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Dr Roger Aston
Wed, 14 May 2008
05:30PM Australia/NSW
Boardroom Radio Tools
Select a tab above to display more information
HALCYGEN PHARMACEUTICALS LIMITED (HGN)
ASX code: HGN
Website: http://www.halcygen.com/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
The testing and improvement of generic drugs
Address:
470 Collins Street, Level 10
MELBOURNE
VIC
Phone: (03) 8614 7777
Fax: (03) 9614 7022
Executives & Directors
Dr Roger Aston , Chairman, CEO
Mr Criag Bottomley , Executive Director, Chief Op. Officer
The Hon Ron Best , Non Exec. Director
Mr Bruce Mathieson , Non Exec. Director
Mr Ian Scholes , Non Exec. Director
Mr Aaron Finlay , CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
HALCYGEN PHARMACEUTICALS LIMITED (HGN) Events
| Company (Stock Code) | Date/Time | Event | Timezone: Australia/NSW |
|---|---|---|---|
|
Wed, 14 May 2008 05:30PM |
HGN - Submission of IND Application to US FDA - Dr Roger Aston, CEO |
     |
| Fri, 21 Nov 2008 11:00AM 11:00AM Australia/Victoria |
Annual General Meeting Stamford Plaza Hotel, 111 Little Collins St, Melbourne, VIC
|
||
| Mon, 20 Oct 2008 | Full Year Results | ||
| Fri, 29 Feb 2008 | Interim Results | ||
| Tue, 20 Nov 2007 10:00AM |
Annual General Meeting Batman's Hill on Collins, 623 Collins Street Melbourne VIC
|
||
| Fri, 31 Aug 2007 | Full Year Results | ||
| Thu, 28 Jun 2007 | Full Year Results | ||
HALCYGEN PHARMACEUTICALS LIMITED (HGN)
| Annual General Meeting Presentation | Fri, 21 Nov 2008 |
| Results of Meeting | Fri, 21 Nov 2008 |
| Second Study Recruitment and Dosing Completed | Fri, 21 Nov 2008 |
| Appendix 4C - quarterly | Mon, 27 Oct 2008 |
| Notice of Annual General Meeting | Mon, 20 Oct 2008 |
| Annual Report to shareholders | Mon, 20 Oct 2008 |
| Change of Director`s Interest Notice | Fri, 17 Oct 2008 |
| Change of Director`s Interest Notice | Wed, 15 Oct 2008 |
| Change of Director`s Interest Notice | Tue, 14 Oct 2008 |
| First successful pivotal trial complete | Tue, 7 Oct 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
